menu
    • menu

    Company profile for MiMedx

    NEW Drugs in Dev: 11
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MiMedx is an industry leader in advanced wound care and a therapeutic biologics company. As a company, we are driven to bring hope to people with hard-to-heal wounds. Our ability to advance science will further differentiate the value of our business and set the foundation for our platform portfolio to address other areas of unmet need.MiMedx has supplied over 2 million allografts, through both direct and consignment shipments...
    MiMedx is an industry leader in advanced wound care and a therapeutic biologics company. As a company, we are driven to bring hope to people with hard-to-heal wounds. Our ability to advance science will further differentiate the value of our business and set the foundation for our platform portfolio to address other areas of unmet need.MiMedx has supplied over 2 million allografts, through both direct and consignment shipments.Patients suffering from chronic, hard-to-heal wounds are one of the most underdiagnosed, undertreated, underserved populations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MiMedxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1775 West Oak Commons Ct. NE Marietta, GA 30062
    Telephone
    Telephone
    888.543.1917
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mimedx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mimedx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MIMEDX To Attend Craig-Hallum 23rd Investor Conference
    MIMEDX To Attend Craig-Hallum 23rd Investor Conference

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299335/0/en/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    MIMEDX Announces Launch Of G4Derm® Plus
    MIMEDX Announces Launch Of G4Derm® Plus

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291038/0/en/mimedx-announces-launch-of-g4derm-plus.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    MIMEDX Announces First Quarter 2026 Operating & Financial Results
    MIMEDX Announces First Quarter 2026 Operating & Financial Results

    29 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7248230

    FIRSTWORD PHARMA
    29 Apr 2026
    Share Share
    MIMEDX To Host Q1 2026 Operating Results Conference Call
    MIMEDX To Host Q1 2026 Operating Results Conference Call

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3278892/0/en/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    MIMEDX Announces Restructuring And Cost Reduction Initiative
    MIMEDX Announces Restructuring And Cost Reduction Initiative

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275283/0/en/MIMEDX-Announces-Restructuring-and-Cost-Reduction-Initiative.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    MIMEDX To Sponsor Leading Advanced Wound Care Conferences
    MIMEDX To Sponsor Leading Advanced Wound Care Conferences

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267431/0/en/MIMEDX-to-Sponsor-Leading-Advanced-Wound-Care-Conferences.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search